.svg "CTA Arrow")
.png)
News & Insights from IRC Partners
IRC Partners publishes institutional-grade research on capital stack structuring, GP/LP economics, debt and equity positioning, fund formation, and LP due diligence for real estate sponsors and growth-stage founders.
Each article is written to the standard institutional investors use to evaluate sponsors, not as general education.
May 20, 2026
What Happens to Your Cap Table When a Key Investor Goes Silent: How Zombie Investors Block Series B Governance Votes
Zombie investors holding preferred stock retain full voting power. Learn how to map class thresholds and navigate dark holders before Series B close.
May 20, 2026
How Acqui-Hire Attempts and Failed M&A Discussions Leave Cap Table Scars That Series B Investors Always Find
Failed M&A or acqui-hire attempts leave corporate record scars. Learn to clean up unrescinded board resolutions and retention equity before Series B.
May 19, 2026
Founder Vesting Cliffs and Acceleration Provisions: The Cap Table Footnotes That Scare Series B Investors Away
Founder vesting and acceleration issues can spook Series B investors. Learn to audit agreements and fix single-trigger risks before diligence.
%20Elections%20Create%20a%20Tax%20Time%20Bomb%20at%20Series%20B.webp "How Missing 83(b) Elections Create a Tax Time Bomb at Series B")
May 19, 2026
How Missing 83(b) Elections on Founder and Employee Stock Create a Tax Time Bomb That Surfaces in Series B Diligence
Missing 83(b) elections trigger massive tax liabilities during Series B. Learn to audit equity files before investors find the gap.
May 19, 2026
How Unpaid Founder Salaries Converted to Equity Create Hidden Cap Table Liabilities That Derail Series B Diligence
Unpaid founder salaries converted to equity without proper paperwork introduce severe cap table defects. Learn how to audit these un-released wage claims, mitigate 409A tax exposure, and legally formalize your equity history before institutional Series B due diligence begins.
May 18, 2026
Phantom Equity and SARs: How Non-Standard Equity Instruments Create Series B Valuation and Governance Confusion
Non-standard instruments like phantom equity and SARs can quietly derail an institutional Series B. Learn how to model contingent cash obligations, address liability accounting risks under ASC 718, and ensure clean structural subordination before entering diligence.
May 18, 2026
What Happens to Your Warrants at Series B: Why Legacy Warrant Overhang Kills Institutional Deals Quietly
Legacy warrants can quietly pollute a cap table and derail an institutional Series B. Learn how to identify invisible dilution, handle cashless exercise formulas, and manage lender-consent constraints before entering institutional diligence.
May 18, 2026
How Equity Grants to Advisors, Contractors, and Strategic Partners Quietly Pollute Your Cap Table Before Series B
Non-employee equity grants to advisors, contractors, and partners can quietly pollute your cap table and stall a Series B. Learn how to audit undocumented grants, address 409A and IP risks, and clean up your equity structure before institutional diligence begins.
May 15, 2026
The Offshore Entity Problem: How Holding Companies, Cayman Structures, and Offshore Cap Table Layers Block US Institutional Series B Investment
Offshore layers like Cayman or BVI holdcos can completely block U.S. institutional Series B investment. Learn how to identify structural blockers—from CFIUS reviews to UBTI exposure—and successfully execute a cap table reorganization.
Schedule A Meeting
You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.
We onboard a maximum of seven
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.
